Miriam A. Hickey

Prof. Miriam A. Hickey

University of Tartu
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in Neuroscience
Verified
Journal Article
Closed access
Miriam A. HickeyMiriam A. Hickey
Miriam A. Hickey
AKA. Kosmalska
A. Kosmalska
JEJ. Enayati
J. Enayati
RCR. Cohen
R. Cohen
SZS. Zeitlin
S. Zeitlin
MCM.-F. Chesselet
M.-F. Chesselet

1 November 2004 in Trends in Neurosciences
Verified
Journal Article
Closed access
MLMichael Levine
Michael Levine
CCCarlos Cepeda
Carlos Cepeda
Miriam A. HickeyMiriam A. Hickey
Miriam A. Hickey
SFSheila M. Fleming
Sheila M. Fleming
MCMarie-Françoise Chesselet
Marie-Françoise Chesselet

1 April 2003 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
Miriam A. HickeyMiriam A. Hickey
Miriam A. Hickey
MCMarie-Françoise Chesselet
Marie-Françoise Chesselet

19 July 2016 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MCMichal Cagalinec
Michal Cagalinec
MLMailis Liiv
Mailis Liiv
ZHZuzana Hodurova
Zuzana Hodurova
Miriam A. HickeyMiriam A. Hickey
Miriam A. Hickey
AVAnnika Vaarmann
Annika Vaarmann
AKAllen Kaasik
Allen Kaasik
Deficiency of the protein Wolfram syndrome 1 (WFS1) is associated with multiple neurological and psychiatric abnormalities similar to those observed in pathologies showing alterations in mitochondrial dynamics. The aim of this study was to examine the hypothesis that WFS1 deficiency affects neuronal function via mitochondrial abnormalities. We show that down-regulation of WFS1 in neurons leads to dramatic changes in mitochondrial dynamics (inhibited mitochondrial fusion, altered mitochondrial trafficking, and augmented mitophagy), delaying neuronal development. WFS1 deficiency induces endoplasmic reticulum (ER) stress, leading to inositol 1,4,5-trisphosphate receptor (IP3R) dysfunction and disturbed cytosolic Ca2+ homeostasis, which, in turn, alters mitochondrial dynamics. Importantly, ER stress, impaired Ca2+ homeostasis, altered mitochondrial dynamics, and delayed neuronal development are causatively related events because interventions at all these levels improved the downstream processes. Our data shed light on the mechanisms of neuronal abnormalities in Wolfram syndrome and point out potential therapeutic targets. This work may have broader implications for understanding the role of mitochondrial dynamics in neuropsychiatric diseases. Wolfram syndrome (WS) is a genetic disorder characterized by diabetes insipidus, diabetes mellitus, optic atrophy, deafness, and brain atrophy. Brain abnormalities occur at the earliest stage of clinical symptoms, suggesting that Wolfram syndrome has a pronounced impact on early brain development. The majority of Wolfram syndrome cases are caused by mutations in the gene Wolfram syndrome 1 (WFS1), which encodes for a protein localized to the endoplasmic reticulum (ER) membrane. However, the clinical symptoms of WS resemble mitochondrial disease symptoms, suggesting strong mitochondrial involvement. In this manuscript, we demonstrate that deficiency of the gene WFS1 triggers an ER-stress cascade, which impairs the function of the IP3-receptor calcium channel, leading to altered calcium homeostasis. The latter leads to dysregulation of mitochondrial dynamics, as characterized by augmented mitophagy—a selective degradation of mitochondria—and inhibited mitochondrial trafficking and fusion, which results in lower levels of ATP and, thus, inhibits neuronal development. These results shed new light onto the mechanisms of neuronal abnormalities in Wolfram syndrome and point out potentially new therapeutic targets. Moreover, our results unravel two rather unexpected links that have an impact beyond the relatively rare Wolfram syndrome. First, relatively mild stress of the ER can seriously disturb mitochondrial dynamics, explaining why alterations at the level of the ER could lead to a mitochondrial phenotype. Second, increased levels of mitophagy, leading to excessive and unwanted mitochondrial clearance, are harmful for neurons. Furthermore, since alterations in the gene WFS1 take place in different neurologic and psychiatric disorders, our work may also have broad implications for understanding the role of mitochondrial dynamics in neuropsychiatric diseases.

7 May 2021 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
JIJürgen Innos
Jürgen Innos
Miriam A. HickeyMiriam A. Hickey
Miriam A. Hickey

8 June 2010 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JGJuliette D Godin
Juliette D Godin
GPGhislaine Poizat
Ghislaine Poizat
Miriam A. HickeyMiriam A. Hickey
Miriam A. Hickey
FMFlorence Maschat
Florence Maschat
SHSandrine Humbert
Sandrine Humbert
Huntington's disease (HD) is a fatal neurodegenerative disorder causing selective neuronal death in the brain. Dysfunction of the ubiquitin–proteasome system may contribute to the disease; however, the exact mechanisms are still unknown. We report here a new pathological mechanism by which mutant huntingtin specifically interferes with the degradation of β‐catenin. Huntingtin associates with the β‐catenin destruction complex that ensures its equilibrated degradation. The binding of β‐catenin to the destruction complex is altered in HD, leading to the toxic stabilization of β‐catenin. As a consequence, the β‐transducin repeat‐containing protein (β‐TrCP) rescues polyglutamine (polyQ)‐huntingtin‐induced toxicity in striatal neurons and in a Drosophila model of HD, through the specific degradation of β‐catenin. Finally, the non‐steroidal anti‐inflammatory drug indomethacin that decreases β‐catenin levels has a neuroprotective effect in a neuronal model of HD and in Drosophila and increases the lifespan of HD flies. We thus suggest that restoring β‐catenin homeostasis in HD is of therapeutic interest.